Oromandibular dystonia is characterized by sustained muscle contractions of the face, jaw, and/or tongue that cause difficulty in opening and closing the mouth, and often affects chewing, swallowing and speech, possibly leading to trismus and clenching. The etiology of oromandibular dystonia is varied and includes genetic predisposition, central nervous system injury, peripheral trauma, medication, metabolic or toxic state, and neurodegenerative disease. First-line treatment for oromandibular dystonia is botulinum toxin, and approximately 60% of treated patients experience improvements in chewing and speech after injection into the masseter, temporalis, or lateral pterygoid muscles. Furthermore, other medications are used, such as anticholinergic drugs, benzodiazepine, and anticonvulsants. Oromandibular dystonia may respond to sensory tricks to temporarily reduce symptoms, such as gently touching the lips or chin, chewing gum, talking, biting on a toothpick, or placing a finger underneath the chin may cause symptoms to temporarily subside, and which is accompanied by the modulation of sensorimotor cortex activities, as well as application of botulinum toxin. Affected patients with oromandibular dystonia may present psychiatric symptoms, such as depression, anxiety, obsessive-compulsive disorder, schizoid personality, space phobia, and other psychological abnormalities, and the psychological profile may further confuse the clinician and confound the diagnosis. Our recent findings show that treatment by injection of botulinum toxin into persistently contracted oromandibular and maxillofacial muscles in patients with idiopathic oromandibular dystonia is valid to alleviate not only the dystonic muscle activities, but also pain awareness and psychiatric mood states. The purpose of this review is to provide a basis for a comprehensive understanding of oromandibular dystonia.
View full abstract